You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
DRUG MONITORING, METHYLPHENIDATE METABOLITE, QUANTITATIVE, URINE |
||
Geisinger Epic Procedure Code: LAB1310
Geisinger Epic ID: 53165
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Random urine | |
Preferred collection container: |
||
Alternate Collection Container: |
Non-sterile specimen container
|
|
Specimen required: |
20 mL random urine; minimum 5 mL. | |
| SPECIMEN PROCESSING |
||
Transport temperature: |
Refrigerated. | |
Specimen stability: |
Room temperature: 5 days. Refrigerated: 7 days. Frozen: 30 days. | |
Rejection criteria: |
Preserved samples. | |
TEST DETAILS |
||
Additional information: |
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | |
CPT code(s): |
80360 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Ritalinic Acid | |
Methodology: |
Mass Spectrometry |
|
Synonyms: |
Quest test code 39409, DM Methlphen, Ritalin
|
|
Clinical significance: |
The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications aren't diverted, and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s). | |